Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111Inpentetreotide in patients with advanced neuroendocrine tumours - Helisch, A; Förster, GJ; Reber, H (Eur J Nucl Med Mol Imaging, 2004)